Futures
Access hundreds of perpetual contracts
CFD
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
GateRouter
Smartly choose from 40+ AI models, with 0% extra fees
#ChipStocksCrashedDowHitRecordHigh
The Market Just Sent a Clear Message. AI Hype Is Cooling. Old School Blue Chips Are Back.
June 4 was one of those rare days that tells you exactly where the market's head is at. While the headlines screamed about Broadcom's collapse, the real story was hiding in plain sight. Money is rotating out of the AI trade and into something else entirely. Let me walk you through what happened and why it matters more than you think.
Broadcom was the catalyst. The chip giant reported earnings that would have been considered spectacular in any other era. Revenue hit $22.19 billion, up 48% from a year ago. Their AI semiconductor revenue surged 143% to $10.8 billion. Free cash flow came in at a massive $10.26 billion. By any normal measure, this was a blowout quarter. But the stock cratered 11%, wiping out roughly $286 billion in market value. Why? Because CEO Hock Tan did not raise guidance.
Here is the thing about markets at extremes. Expectations get so inflated that good news becomes bad news. Analysts wanted Tan to raise his 2027 AI revenue forecast above $100 billion. He stuck to the number. He even tried to calm nerves by saying Broadcom would ship over 10 gigawatts of AI chips in 2027. The market did not care. The bar was simply too high.
The reaction was brutal and immediate. Broadcom's drop triggered a chain reaction across the entire semiconductor complex. Micron fell nearly 8%. AMD dropped 4%. Intel slid 3%. Arm Holdings lost over 4%. The Philadelphia Semiconductor Index, which tracks the chip sector, fell more than 2%. This was not just one company missing expectations. This was the market rethinking the entire AI infrastructure trade.
But here is where it gets interesting. While tech was bleeding, the Dow Jones Industrial Average was having its best day in months. It surged nearly 810 points to close at 51,496, a fresh all-time high. The S&P 500 managed a modest 0.53% gain. The Nasdaq barely scraped together a 0.23% advance. This divergence tells you everything about where money is flowing.
The leaders were not the usual suspects. Healthcare stocks powered the rally. UnitedHealth and the healthcare complex carried significant weight. Financials surged alongside them. Goldman Sachs jumped 4.4%. JPMorgan and American Express each gained more than 3.3%. These are not growth stocks. These are mature, profitable, dividend-paying companies that have been largely ignored during the AI frenzy.
This rotation has been building for weeks, but June 4 made it impossible to ignore. The market is repricing risk. For months, investors have piled into anything with an AI story. Semiconductors have been the best-performing sector in the S&P 500 by a massive margin. The Philadelphia Semiconductor Index had been on pace for its best quarter ever after soaring 69% in just two months. Nearly 80% of the S&P 500's gains this year came from just ten companies, seven of which were semiconductor stocks. That kind of concentration is unsustainable.
What we are witnessing is a classic market rotation. When one trade gets too crowded, money seeks the path of least resistance. Healthcare and financials offer something that AI stocks no longer do at these prices. They offer reasonable valuations. They offer dividend yields. They offer stability in an uncertain world. Most importantly, they offer a place to hide when the momentum trade reverses.
The Broadcom selloff is particularly telling because it highlights a growing skepticism about AI infrastructure spending. Companies like Broadcom, Nvidia, and Marvell have been selling the picks and shovels of the AI gold rush. Their custom chips power the data centers training large language models. But investors are starting to ask questions. Is this spending sustainable? Are the returns on AI investment materializing fast enough? Are we building too much capacity too quickly?
Broadcom's guidance suggests the growth will continue, just not accelerate. That should be fine. But when a stock trades at extreme multiples, fine is not good enough. The market wanted acceleration. It got stability instead. The punishment was swift and severe.
The broader implications are worth considering. If AI infrastructure spending slows, the entire semiconductor food chain feels it. Memory chip makers like Micron and SK Hynix have ridden the AI wave to massive gains. Equipment makers like Applied Materials have benefited from data center expansion. If the capital expenditure boom moderates, all of these stories get repriced.
At the same time, the strength in healthcare and financials suggests investors are not abandoning the market. They are just rotating to safer ground. This is actually a healthy development. Markets work best when leadership broadens. When a handful of stocks drive all the gains, risk builds under the surface. When money flows to different sectors, the foundation gets stronger.
The Dow's record close is significant because it represents a different kind of market than the Nasdaq. The Dow is weighted by price, not market cap, so it gives more influence to established industrial names. It includes companies like UnitedHealth, Johnson & Johnson, and JPMorgan alongside tech names like Apple and Microsoft. When the Dow leads, it often signals a shift in investor preference toward quality and away from speculation.
Goldman Sachs leading the charge is especially notable. Banks have been relative laggards for years. They benefit from higher interest rates, stable economic growth, and reduced regulatory uncertainty. After years of trading at depressed valuations, they offer genuine value. When money rotates out of expensive tech and into cheap financials, that is a bet on normalization.
The healthcare rally makes similar sense. These are defensive growth companies with pricing power and demographic tailwinds. They do not depend on AI hype. They depend on aging populations and rising healthcare spending. That is a much more predictable bet than guessing which AI model will win.
What happens next depends on whether this rotation has legs or proves temporary. If AI stocks stabilize and resume their uptrend, this could be just a brief pause. But if more companies fail to meet inflated expectations, the selling could accelerate. The market has given AI stocks a very long leash. That leash is getting shorter.
For investors, the lesson is clear. Chasing momentum works until it doesn't. The best trades are often the ones that feel uncomfortable. Buying healthcare when everyone is talking about AI. Buying banks when everyone is obsessed with semiconductors. These are the rotations that create opportunity while others are looking elsewhere.
June 4 was a wake-up call. The AI trade is not dead, but it is no longer the only game in town. Smart money is diversifying. The question is whether you are paying attention.